Webinars

Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”
Exclusive study “Use of NGS to replace animal tests for the viral safety of biologics”

The industry needs to bring safer biologics to patient in a more ethical and time effective. Classical viral safety testing approaches often fail to keep pace with the demands faced with new and innovative biomedicines and they have fallen out of favor considering the 3Rs (replacement, reduction, refinement of animal testing). See the calendar in regards with the presentation of the new comparison study between NGS and in vivo.

read more

Click here to learn more about PathoQuest’s Biologics Genomic Service for biopharmaceutical companies.

Connect